Angioedema :: Treatments emerge for a rare and life-threatening disease angioedema
An investigational drug called ecallantide (also known as DX-88 [Dyax Corp., Cambridge, MA]) significantly relieves attacks of a rare, life-threatening disease called hereditary angioedema, report researchers from Children’s Hospital Boston and 25 other study sites.